BlackRock TCP Capital Corp vs Twist Bioscience Corp — how do they compare? BlackRock TCP Capital Corp trades at $3.24 (market cap $270.17M), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Twist Bioscience Corp is far larger — about 20.2× BlackRock TCP Capital Corp's market cap, and BlackRock TCP Capital Corp pays a 26.09% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| TCPC | TWST | |
|---|---|---|
Market Cap | $270.17M | $5.45B |
Sector | Financials | Health |
52-Week High | $7.64 | $102.88 |
52-Week Low | $3.14 | $24.16 |
Dividend Yield | 26.09% | — |
Enterprise Value | — | $5.37B |
Trailing returns across standard periods
Latest headlines on both assets
BlackRock TCP Capital Corp is a finance company specializing in middle-market lending. It aims for high returns through income and capital appreciation while prioritizing principal protection. The company invests in debt securities and earns revenue from interest payments, fees, and some equity appreciation.
Read more on TCPC →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →